Loading stock data…
$25.75-1.22 (-4.52%)
Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. in the Healthcare sector is trading at $25.91 with a market capitalization of $1.5B. Wall Street consensus targets $30.29 (7 analysts), implying a +16.9% move over the next 12 months. The stock is currently 14% below its 52-week high of $30.00, remaining 9.9% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $28.64M↑ | $24.55M↑ | $22.57M↑ | $19.37M↑ | $17.23M |
| Gross Profit | $15.68M↑ | $12.91M↑ | $11.42M↑ | $8.85M↑ | $7.63M |
| Operating Income | -$39.34M↓ | -$34.77M↓ | -$31.75M↓ | -$28.88M↑ | -$48.21M |
| Net Income | -$38.84M↓ | -$34.17M↓ | -$32.78M↓ | -$25.83M↑ | -$52.05M |
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clin...